Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


Oliena Studio

Stroke and language recovery: 9000+ videos

EspañolItalianoSarduEnglish | PDF+


  Head and Neck Cancer

  Free Subscription


05.08.2019

1 Ann Surg
7 Anticancer Res
1 Br J Oral Maxillofac Surg
3 Cancer
2 Clin Cancer Res
2 Gastrointest Endosc
3 Head Neck
2 Histopathology
1 Int J Cancer
1 Int J Radiat Oncol Biol Phys
2 J Clin Oncol
4 Laryngoscope
14 Oral Oncol
1 Thyroid


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Ann Surg

  1. SAKAMOTO T, Fujiogi M, Matsui H, Fushimi K, et al
    Comparing Perioperative Mortality and Morbidity of Minimally Invasive Esophagectomy Versus Open Esophagectomy for Esophageal Cancer: A Nationwide Retrospective Analysis.
    Ann Surg. 2019 Jul 25. doi: 10.1097/SLA.0000000000003500.
    PubMed     Text format     Abstract available


    Anticancer Res

  2. MATSUNAGA N, Wakasaki T, Yasumatsu R, Kotake Y, et al
    Long Noncoding RNA, ANRIL, Regulates the Proliferation of Head and Neck Squamous Cell Carcinoma.
    Anticancer Res. 2019;39:4073-4077.
    PubMed     Text format     Abstract available

  3. MATSUMOTO A, Yuda M, Tanaka Y, Tanishima Y, et al
    Efficacy of Percutaneous Endoscopic Gastrostomy for Patients With Esophageal Cancer During Preoperative Therapy.
    Anticancer Res. 2019;39:4243-4248.
    PubMed     Text format     Abstract available

  4. JINGU K, Takahashi N, Murakami Y, Ishikawa K, et al
    Is Concurrent Chemotherapy With Radiotherapy for Esophageal Cancer Beneficial in Patients Aged 80 Years or Older?
    Anticancer Res. 2019;39:4279-4283.
    PubMed     Text format     Abstract available

  5. NAKANO K, Seto A, Sasaki T, Shimbashi W, et al
    Predictive Factors for Completion of TPF Induction Chemotherapy in Patients With Locally Advanced Head and Neck Cancer.
    Anticancer Res. 2019;39:4337-4342.
    PubMed     Text format     Abstract available

  6. OHSAWA M, Hamai Y, Ibuki Y, Emi M, et al
    Long-term Esophageal Cancer Survivor Treated by Bypass for Esophagobronchial Fistula After Chemoradiotherapy: A Case Report.
    Anticancer Res. 2019;39:4399-4403.
    PubMed     Text format     Abstract available

  7. TANAKA Y, Ueno T, Yoshida N, Akutsu Y, et al
    Is Oral Mucositis Occurring During Chemotherapy for Esophageal Cancer Patients Correctly Judged? EPOC Observational Cohort Study.
    Anticancer Res. 2019;39:4441-4448.
    PubMed     Text format     Abstract available

  8. FUKUOKA E, Yamashita K, Tanaka T, Sawada R, et al
    Neoadjuvant Chemotherapy Increases PD-L1 Expression and CD8(+) Tumor-infiltrating Lymphocytes in Esophageal Squamous Cell Carcinoma.
    Anticancer Res. 2019;39:4539-4548.
    PubMed     Text format     Abstract available


    Br J Oral Maxillofac Surg

  9. TIGHE D, Thomas AJ, Hills A, Quadros R, et al
    Validating a risk stratification tool for audit of early outcome after operations for squamous cell carcinoma of the head and neck.
    Br J Oral Maxillofac Surg. 2019 Jul 25. pii: S0266-4356(19)30273.
    PubMed     Text format     Abstract available


    Cancer

  10. SHAO D, Vogtmann E, Liu A, Qin J, et al
    Microbial characterization of esophageal squamous cell carcinoma and gastric cardia adenocarcinoma from a high-risk region of China.
    Cancer. 2019 Jul 29. doi: 10.1002/cncr.32403.
    PubMed     Text format     Abstract available

  11. ECONOMIDES MP, Amit M, Mahale PS, Hosry JJ, et al
    Impact of chronic hepatitis C virus infection on the survival of patients with oropharyngeal cancer.
    Cancer. 2017 Nov 17. doi: 10.1002/cncr.31146.
    PubMed     Text format     Abstract available

  12. ROTH MY, Witt RL, Steward DL
    Molecular testing for thyroid nodules: Review and current state.
    Cancer. 2017 Dec 26. doi: 10.1002/cncr.30708.
    PubMed     Text format     Abstract available


    Clin Cancer Res

  13. OH SH, Kim WY, Kim JH, Younes MN, et al
    Editor's Note: Identification of Insulin-Like Growth Factor Binding Protein-3 as a Farnesyl Transferase Inhibitor SCH66336-Induced Negative Regulator of Angiogenesis in Head and Neck Squamous Cell Carcinoma.
    Clin Cancer Res. 2019;25:4861.
    PubMed     Text format    

  14. YAMAMURA K, Izumi D, Kandimalla R, Sonohara F, et al
    Intratumoral Fusobacterium nucleatum levels predict therapeutic response to neoadjuvant chemotherapy in esophageal squamous cell carcinoma.
    Clin Cancer Res. 2019 Jul 29. pii: 1078-0432.CCR-19-0318.
    PubMed     Text format     Abstract available


    Gastrointest Endosc

  15. YU X, van Munster SN, Zhang Y, Xue L, et al
    Durability of radiofrequency ablation for treatment of esophageal squamous cell neoplasia: 5-year follow-up of a treated cohort in China.
    Gastrointest Endosc. 2019;89:736-748.
    PubMed     Text format     Abstract available

  16. PEERALLY MF, Bhandari P, Ragunath K, Barr H, et al
    Radiofrequency ablation compared with argon plasma coagulation after endoscopic resection of high-grade dysplasia or stage T1 adenocarcinoma in Barrett's esophagus: a randomized pilot study (BRIDE).
    Gastrointest Endosc. 2019;89:680-689.
    PubMed     Text format     Abstract available


    Head Neck

  17. ORLANDI E, Bonomo P, Ferella L, D'Angelo E, et al
    Long-term outcome of re-irradiation for recurrent or second primary head and neck cancer: A multi-institutional study of AIRO-Head and Neck working group.
    Head Neck. 2019 Jul 29. doi: 10.1002/hed.25890.
    PubMed     Text format     Abstract available

  18. JAKOB M, Mattes LM, Kuffer S, Unger K, et al
    MicroRNA expression patterns in oral squamous cell carcinoma: hsa-mir-99b-3p and hsa-mir-100-5p as novel prognostic markers for oral cancer.
    Head Neck. 2019 Jul 29. doi: 10.1002/hed.25866.
    PubMed     Text format     Abstract available

  19. KWAN BYM, Khan NM, de Almeida JR, Goldstein D, et al
    Transoral robotic surgery for head and neck malignancies: Imaging features in presurgical workup.
    Head Neck. 2019 Aug 1. doi: 10.1002/hed.25887.
    PubMed     Text format     Abstract available


    Histopathology

  20. YU P, Wang W, Zhuang Z, Xie N, et al
    A novel prognostic model for tongue squamous cell carcinoma based on the characteristics of tumour and its microenvironment: iBD score.
    Histopathology. 2019;74:766-779.
    PubMed     Text format     Abstract available

  21. WU J, Zhang Y, Cheng R, Gong W, et al
    Expression of epithelial-mesenchymal transition regulators TWIST, SLUG and SNAIL in follicular thyroid tumours may relate to widely invasive, poorly differentiated and distant metastasis.
    Histopathology. 2019;74:780-791.
    PubMed     Text format     Abstract available


    Int J Cancer

  22. ANUSIC T, Gianicolo EAL
    Comment on "A prospective study of tea drinking temperature and risk of esophageal squamous cell carcinoma" by Islami et al.
    Int J Cancer. 2019 Jul 31. doi: 10.1002/ijc.32601.
    PubMed     Text format    


    Int J Radiat Oncol Biol Phys

  23. HELD T, Windisch P, Akbaba S, Lang K, et al
    Carbon Ion Re-Irradiation for Recurrent Head-and-Neck Cancer: A Single-Institutional Experience.
    Int J Radiat Oncol Biol Phys. 2019 Jul 23. pii: S0360-3016(19)33504.
    PubMed     Text format     Abstract available


    J Clin Oncol

  24. FISHER R
    Questionable Relevance of Leukemia Risk After Radioiodine Ablation of Thyroid Cancer.
    J Clin Oncol. 2018 May 3:JCO2018781534. doi: 10.1200/JCO.2018.78.1534.
    PubMed     Text format    

  25. PICCARDO A, Puntoni M, Verburg FA, Luster M, et al
    Power of Absolute Values to Avoid Data Misinterpretations: The Case of Radioiodine-Induced Leukemia and Myelodysplasia.
    J Clin Oncol. 2018 May 3:JCO2018777318. doi: 10.1200/JCO.2018.77.7318.
    PubMed     Text format    


    Laryngoscope

  26. GOROSTIS S, Raguin T, Schneegans O, Takeda C, et al
    Incidental thyroid papillary microcarcinoma: survival and follow-up.
    Laryngoscope. 2019;129:1722-1726.
    PubMed     Text format     Abstract available

  27. RYAN JF, Motz KM, Rooper LM, Mydlarz WK, et al
    The Impact of a Stepwise Approach to Primary Tumor Detection in Squamous Cell Carcinoma of the Neck With Unknown Primary.
    Laryngoscope. 2019;129:1610-1616.
    PubMed     Text format     Abstract available

  28. TAM K, Orosco RK, Dimitrios Colevas A, Bedi N, et al
    Cost comparison of treatment for oropharyngeal carcinoma.
    Laryngoscope. 2019;129:1604-1609.
    PubMed     Text format     Abstract available

  29. MYERS LL, Ahn C
    Cutaneous squamous cell carcinoma metastasis to the parotid region lymph nodes.
    Laryngoscope. 2019;129:1579-1586.
    PubMed     Text format     Abstract available


    Oral Oncol

  30. ZHANG Y, Zhang ZC, Li WF, Liu X, et al
    Prognosis and staging of parotid lymph node metastasis in nasopharyngeal carcinoma: An analysis in 10,126 patients.
    Oral Oncol. 2019;95:150-156.
    PubMed     Text format     Abstract available

  31. PARK SJ, Ye W, Xiao R, Silvin C, et al
    Cisplatin and oxaliplatin induce similar immunogenic changes in preclinical models of head and neck cancer.
    Oral Oncol. 2019;95:127-135.
    PubMed     Text format     Abstract available

  32. BARBOSA DA SILVA JL, Doty RL, Miyazaki JVMK, Borges R, et al
    Gustatory disturbances occur in patients with head and neck cancer who undergo radiotherapy not directed to the oral cavity.
    Oral Oncol. 2019;95:115-119.
    PubMed     Text format     Abstract available

  33. DAUZIER E, Lacas B, Blanchard P, Le QT, et al
    Role of chemotherapy in 5000 patients with head and neck cancer treated by curative surgery: A subgroup analysis of the meta-analysis of chemotherapy in head and neck cancer.
    Oral Oncol. 2019;95:106-114.
    PubMed     Text format     Abstract available

  34. SALUJA TS, Iyer J, Singh SK
    Leiomyosarcoma: Prognostic outline of a rare head and neck malignancy.
    Oral Oncol. 2019;95:100-105.
    PubMed     Text format     Abstract available

  35. ARGYRIS PP, Slama Z, Malz C, Koutlas IG, et al
    Intracellular calprotectin (S100A8/A9) controls epithelial differentiation and caspase-mediated cleavage of EGFR in head and neck squamous cell carcinoma.
    Oral Oncol. 2019;95:1-10.
    PubMed     Text format     Abstract available

  36. GAU M, Karabajakian A, Reverdy T, Neidhardt EM, et al
    Induction chemotherapy in head and neck cancers: Results and controversies.
    Oral Oncol. 2019;95:164-169.
    PubMed     Text format     Abstract available

  37. ZHAI TT, Langendijk JA, van Dijk LV, Halmos GB, et al
    The prognostic value of CT-based image-biomarkers for head and neck cancer patients treated with definitive (chemo-)radiation.
    Oral Oncol. 2019;95:178-186.
    PubMed     Text format     Abstract available

  38. MADY LJ, Lyu L, Owoc MS, Peddada SD, et al
    Understanding financial toxicity in head and neck cancer survivors.
    Oral Oncol. 2019;95:187-193.
    PubMed     Text format     Abstract available

  39. CHEN YF, Chang KW, Yang IT, Tu HF, et al
    Establishment of syngeneic murine model for oral cancer therapy.
    Oral Oncol. 2019;95:194-201.
    PubMed     Text format     Abstract available

  40. BLAKAJ A, Bonomi M, Gamez ME, Blakaj DM, et al
    Oral mucositis in head and neck cancer: Evidence-based management and review of clinical trial data.
    Oral Oncol. 2019;95:29-34.
    PubMed     Text format     Abstract available

  41. LEONARD BC, Lee ED, Bhola NE, Li H, et al
    ATR inhibition sensitizes HPV(-) and HPV(+) head and neck squamous cell carcinoma to cisplatin.
    Oral Oncol. 2019;95:35-42.
    PubMed     Text format     Abstract available

  42. DONG Y, Ridge JA, Ebersole B, Li T, et al
    Incidence and outcomes of radiation-induced late cranial neuropathy in 10-year survivors of head and neck cancer.
    Oral Oncol. 2019;95:59-64.
    PubMed     Text format     Abstract available

  43. JUNG AR, Roh JL, Kim JS, Choi SH, et al
    Efficacy of head and neck computed tomography for skeletal muscle mass estimation in patients with head and neck cancer.
    Oral Oncol. 2019;95:95-99.
    PubMed     Text format     Abstract available


    Thyroid

  44. QI XP, Jin BY, Li PF, Wang S, et al
    RET S409Y Germline Mutation and Associated Medullary Thyroid Carcinoma.
    Thyroid. 2019 Jul 31. doi: 10.1089/thy.2018.0385.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Head and Neck Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: